Animal Parasiticides Global Market Report 2025

The animal parasiticides market size has grown strongly in recent years. It will grow from $9.39 billion in 2024 to $10.15 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth during the historic period was driven by disease outbreaks, concerns over livestock productivity, increasing pet ownership, government regulations, and advancements in veterinary medicine.

The animal parasiticides market size is expected to see strong growth in the next few years. It will grow to $13.69 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The projected growth during the forecast period is driven by the rising prevalence of zoonotic diseases, an increasing companion animal population, the expansion of livestock farming, innovations in parasiticide formulations, and greater awareness of animal health. Key trends include the development of long-acting formulations, advancements in biologics and vaccines, the application of nanotechnology in drug delivery, precision dosing technologies, and the adoption of digital tracking and monitoring systems.

The rising prevalence of zoonotic diseases is expected to drive the growth of the animal parasiticides market. Zoonotic diseases are infectious illnesses that can be transmitted between animals and humans and are caused by bacteria, viruses, parasites, or fungi. The increasing occurrence of these diseases is influenced by factors such as climate change, antibiotic resistance, inadequate sanitation, and poor hygiene. Animal parasiticides play a crucial role in preventing zoonotic diseases by controlling parasites that serve as vectors or reservoirs for disease transmission. For example, in April 2024, the European Centre for Disease Prevention and Control, a UK-based governmental organization, reported that confirmed brucellosis cases rose to 199 in 2022, compared to 165 cases in 2021. As a result, the growing prevalence of zoonotic diseases is fueling the expansion of the animal parasiticides market.

Leading companies in the animal parasiticides market are focused on developing advanced solutions, such as combination therapy, to improve efficacy, expand parasite control, minimize resistance development, and enhance convenience for pet owners and livestock managers. Combination therapy involves using multiple active agents with different mechanisms of action to treat or prevent diseases, improving effectiveness while reducing the risk of resistance. For instance, in January 2022, Zoetis Inc., a US-based animal health company, received FDA approval for a new label indication of Simparica Trio, recognizing its ability to prevent Borrelia burgdorferi infections by targeting and eliminating Ixodes scapularis vector ticks. This innovative all-in-one chewable tablet provides broad-spectrum protection by effectively killing Ixodes scapularis ticks, the primary vectors of Lyme disease before they can transmit the infection. Its triple-action formula ensures comprehensive parasite control by targeting fleas, ticks, heartworms, roundworms, and hookworms in a single monthly dose.

In September 2022, Zoetis Inc., a US-based animal health company, acquired Jurox Pty Limited for an undisclosed sum. This acquisition aims to expand Zoetis’ veterinary medicine portfolio, which includes over 150 products in areas such as parasiticides, anti-infectives, anesthesia, cardiology, and reproduction. Jurox Pty Limited, an Australia-based company, specializes in developing veterinary medicines for treating livestock and companion animals.

Major players in the animal parasiticides market are Merck & Co. Inc., Bayer AG, Sanofi SA, Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Inc., Ceva Sante Animale S.A., Virbac SA, Dechra Pharmaceuticals plc, Phibro Animal Health Corporation, Vetoquinol SA, Norbrook Laboratories Limited, Neogen Corporation, Indian Immunologicals Ltd., Krka dd Novo Mesto, Bimeda Inc., The Chanelle Group, ECO Animal Health Group plc, Zydus Animal Health and Investments Ltd., Kyoritsu Seiyaku Corporation.

North America was the largest region in the animal parasiticides market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in animal parasiticides report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the animal parasiticides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Animal parasiticides are chemical or biological agents used to prevent, control, and eliminate parasitic infestations in livestock, companion animals, and other domesticated species. These products help protect animals from internal and external parasites, improving overall health and enhancing productivity in agricultural and veterinary settings.

The primary types of animal parasiticides include endoparasiticides, ectoparasiticides, and endectocides. Endoparasiticides are medications formulated to eliminate internal parasites, such as worms, that live within an animal’s body. These parasiticides are used across various livestock, including swine, poultry, ovine, bovine, equine, canine, and feline species. They are administered in different settings, including veterinary clinics and hospitals, animal farms, and home care environments.

The animal parasiticides market research report is one of a series of new reports that provides animal parasiticides market statistics, including animal parasiticides industry global market size, regional shares, competitors with an animal parasiticides market share, detailed animal parasiticides market segments, market trends and opportunities, and any further data you may need to thrive in the animal parasiticides industry. This animal parasiticides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The animal parasiticides market consists of sales of injectable dewormers, feed additives and medicated pellets, sprays and pour-ons, and macrocyclic lactones. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.